valerylsalicylate has been researched along with Disease Models, Animal in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aggarwal, S; Bhateja, D; Dhull, DK; Dhull, RK; Jindal, A; Padi, SS | 1 |
| Al-Dalain, S; Alvarez, D; Candelario-Jalil, E; García-Cabrera, M; González-Falcón, A; León, OS; Martínez, G; Springer, JE | 1 |
2 other study(ies) available for valerylsalicylate and Disease Models, Animal
| Article | Year |
|---|---|
Neuroprotective effect of cyclooxygenase inhibitors in ICV-STZ induced sporadic Alzheimer's disease in rats.
Topics: Alzheimer Disease; Animals; Antibiotics, Antineoplastic; Cyclooxygenase 2 Inhibitors; Disease Models, Animal; Etoricoxib; Injections, Intraventricular; Lipid Peroxidation; Male; Neuroprotective Agents; Pyridines; Rats; Rats, Wistar; Salicylates; Streptozocin; Sulfones | 2012 |
Assessment of the relative contribution of COX-1 and COX-2 isoforms to ischemia-induced oxidative damage and neurodegeneration following transient global cerebral ischemia.
Topics: Animals; Antioxidants; Biomarkers; Cell Count; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Dinoprostone; Disease Models, Animal; Disease Progression; Gerbillinae; Glutathione; Hippocampus; Ischemic Attack, Transient; Isoenzymes; Lactones; Lipid Peroxidation; Male; Neurodegenerative Diseases; Neurons; Neuroprotective Agents; Oxidation-Reduction; Prostaglandin-Endoperoxide Synthases; Salicylates; Sulfones | 2003 |